- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Research and Markets ( http://www.researchandmarkets.com/reports/c50026 ) has announced the addition of the Frost & Sullivan report: "Gene Therapy-Industry Impact" to their offering
This Frost & Sullivan research service entitled "Gene Therapy-Industry Impact" provides an overview of the current developments and advanced technologies in gene therapy, along with a complete analysis of the key market drivers, restraints, applications, and trends that are impacting this field. In this study, Frost & Sullivan's expert analysts thoroughly examine gene-delivery vehicles and technologies, vector design, DNA vaccine design, and the clinical status of product candidates.
The following technologies are covered in this research:
* Gene-delivery vehicles and technologies
* Vector design
* DNA vaccine design
* Clinical status of product candidates
Expert analysts thoroughly examine the following technology sectors in this research:
* Clinical therapeutics
Growing Popularity of DNA Vaccines Boost Advances in Gene Therapy
Gene therapy is likely to be practiced in clinics in the near future, with a number of candidates now in phase II/III trials, showing promising results. The first gene therapy products, already in late-stage clinical trials, are expected to rely on a short-term effect: for example, the killing of cancer cells through immune stimulation or induction of apoptosis (cellular suicide); or the growth of new blood vessels for the treatment of cardiovascular disease. "An important driver for developing new vaccine technologies is the ‘genetic immunization' method of vaccine delivery, that is, DNA vaccines, which promise to be an effective tool for generating strong and long-term immune responses," according to the analyst of the study. "Particularly from the perspective of developing countries, a great advantage of the DNA vaccine concept is the relative ease with which it can be manufactured and the fact that it doesn't require refrigeration."
Some of the disorders for which gene therapies are in development, in part since they are likely to be most amenable to treatment, include hemophilia, cystic fibrosis, cardiovascular disease, and cancer. Other approaches seek to stimulate an immune response, mediate specific cell destruction, activate a pro-drug, or produce a molecular decoy required for the replication of a virus. A number of DNA vaccines are also in clinical trials, and are likely to be developed for infectious diseases such as herpes, hepatitis, and AIDS, as well as various forms of cancer.
Growing Population and Rising Diseases Increases the Need for Vaccines, Driving Advances in Gene Therapy
Novel innovations in polymer chemistry, nanotechnology, and viral vectors, in addition to an increasing understanding of the biology of exogenous gene expression, are likely to overcome the technical obstacles. Significant advances in recombinant DNA technology and genetic engineering have improved ways of introducing new genes into cells. As a result, disease targets for gene therapy have expanded beyond traditional genetic diseases to acute disorders such as cancer, and chronic diseases such as diabetes and cardiovascular disease.
The demand for vaccines is increasing due to the growing population and the growth in the number of diseases. A large number of vaccines under development are anticipated to make the vaccines market an interesting and dynamic one in the near future. "Numerous clinical conditions other than infectious diseases are now being considered within the purview of vaccines," explains the analyst. "These include cancers, allergies, autoimmune diseases such as diabetes, metabolic diseases such as hyperlipidaemias that lead to atherosclerosis, and coronary artery disease, and even addictions such as cocaine and nicotine dependencies."
1. Executive Summary
* 1. Scope and Methodology
* 2. Introduction and History of Gene Therapy
* 3. Technology and Applications Viewpoint
1. Technology Primer
* 2. Applications Analysis and Trends
* 3. Assessment of Stakeholder Innovation and Technology Transfer Opportunities--Influential Market Factors
3. Technology Adoption Factor Analysis
* 1. Regulatory Hurdles
* 2. Technology or Product Development Restraints and Competing Technologies
* 3. Analysis of Drivers
4. Assessment of Innovations and Opportunities
* 1. Innovative Developments in North America--Gene Therapy
* 2. Innovative Developments in North America--DNA Vaccines
* 3. Innovative Developments in Europe--Gene Therapy
* 4. Innovative Developments in Europe--DNA Vaccines
* 5. Innovative Developments in the Asia Pacific Region
5. Patents and Database of Key Industry Participants
* 1. Patents
* 2. Database of Key Industry Participants
6. Decision Support Database
* 1. Database Tables
For more information visit http://www.researchandmarkets.com/reports/c50026
About Research and Markets
We are the leading source for international market research and market data. We hold ‘000’s of major research publications from most of the leading publishers, consultants and analysts. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends
We are a ‘One-Stop-Shop’ for market research reports and industry newsletters from specialist research firms and niche market analysts.
For more information, please click here
Research and Markets
Fax: +353 1 4100 980
Copyright © Business WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Argon is not the 'dope' for metallic hydrogen March 24th, 2017
Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017